Lorenza Bertu
Overview
Explore the profile of Lorenza Bertu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carugno A, Paolino G, Valenti M, Brigenti N, Bertu L, Gianatti A, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941357
: Melanoma is an aggressive cutaneous malignancy with a rising incidence. While most cases are sporadic, 5-10% are hereditary, especially in patients with multiple or familial melanomas. The aim of...
2.
Vajna de Pava M, Samperi M, Bresesti I, Bertu L, Plebani A, Agosti M
Pediatr Emerg Care
. 2024 Nov;
41(2):131-134.
PMID: 39560610
Objectives: Major studies have defined clinical rules to regulate the use of computed tomography in children after head trauma. Infants younger than 3 months are considered at higher risk of...
3.
Abenante A, Squizzato A, Bertu L, Arioli D, Buso R, Carrara D, et al.
Intern Emerg Med
. 2024 Sep;
20(1):151-158.
PMID: 39333275
Patients hospitalized in Internal Medicine Units (IMUs) may frequently experience both an increased risk for thrombosis and bleeding. The use of risk assessment models (RAMs) could aid their management. We...
4.
Coltro G, Capecchi G, Maffioli M, Mannelli F, Mora B, Atanasio A, et al.
Haematologica
. 2024 May;
109(10):3398-3403.
PMID: 38813708
No abstract available.
5.
Carabelli G, Binotto I, Armano C, Bertu L, Luini C, Nosetti L, et al.
Children (Basel)
. 2024 Apr;
11(4).
PMID: 38671666
Background: Nocturnal infant crying is often empirically treated with acid suppressants. The aim of this study was to evaluate the prevalence and characteristics of gastroesophageal reflux (GER) in infants with...
6.
Donadini M, Mumoli N, Fenu P, Pomero F, Re R, Palmiero G, et al.
Diagnostics (Basel)
. 2024 Apr;
14(7).
PMID: 38611689
Background: The Pulmonary Embolism Severity Index (PESI) is an extensively validated prognostic score, but impact analyses of the PESI on management strategies, outcomes and health care costs are lacking. Our...
7.
Mora B, Maffioli M, Rumi E, Guglielmelli P, Caramella M, Kuykendall A, et al.
EJHaem
. 2023 Aug;
4(3):679-689.
PMID: 37601878
Myelofibrosis (MF) is a clonal malignancy frequently characterized by anemia and in 10%-20% of cases it can evolve into blast phase (BP). Anemia in MF is associated with reduced survival...
8.
Conti M, Bolzacchini E, Luchena G, Bertu L, Tagliabue P, Aglione S, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444575
Trifluridine/tipiracil (TAS-102) is an oral chemotherapy approved for the treatment of metastatic colorectal cancer. The efficacy and tolerability of TAS-102 were shown in phase II-III clinical trials and in several...
9.
Guarascio M, Bertu L, Donadini M, Antonucci E, Palareti G, Ageno W
Intern Emerg Med
. 2023 Jun;
18(6):1681-1687.
PMID: 37301770
Background: Direct oral anticoagulants (DOACs) are widely used for the treatment of venous thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However, evidence in obese and underweight patients...
10.
Campanaro F, Zaffaroni A, Cacioppo E, Cappelli A, Bertu L, Donadini M, et al.
Rheumatology (Oxford)
. 2023 May;
62(10):3245-3255.
PMID: 37202344
Objective: Preliminary data led licencing authorities to alert clinicians of an increased venous thrombotic risk associated to the use of Janus kinase (JAK) inhibitors (JAKi). We performed a systematic review...